Ophthalmic Disorders Archives - Page 59 of 59 - MPR

Ophthalmic Disorders

EYLEA (aflibercept) 40mg/mL intravitreal injection by Regeneron

Eylea Gains New Macular Edema Indication

Regeneron announced that the FDA has approved Eylea (aflibercept injection) for the treatment of macular edema following central retinal vein occlusion (CRVO).